Sentinel Oncology

Private

CambridgeHealthcare & Life Scienceshttps://www.sentineloncology.com/

Last Round

Grant

Apr 1, 2018

Total Funding Raised

$10.27M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Sentinel Oncology is a biotechnology company that develops and commercializes new therapeutics for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

drug discoverysmall molecule drugsoncology therapeuticsdrug licensingbiotechChk1 inhibitorbrain cancer therapeuticsblood-brain barrier penetrationpreclinical drug developmentselective kinase inhibitorsmedicinal chemistrybrain metastasesPLK1 inhibitorS6K1 inhibitortriple-negative breast cancerFragile X syndrome

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sentinel Oncology Comparables

Compare Sentinel Oncology with similar companies based on industry and business-model similarity.

Sentinel Oncology comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Sareum Holdings plc	85%
Kazia Therapeutics	77%
PharmaEngine, Inc.	76%

View all Comparables

Sentinel Oncology Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 1, 2018
Grant	Aug 4, 2017
Grant	Aug 8, 2015
Grant	Oct 31, 2013
Grant	Apr 19, 2011
Grant	Jan 1, 2008

View all Funding Rounds

Sentinel Oncology Investors

Notable investors and investment history

Sentinel Oncology investors
Investor	Rounds
Eurostars SME programme	Grant
Cambridge Enterprise	Seed
Innovate UK	Grant
Medical Research Council	Grant
Wellcome Trust	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 16, 2026
Monthly visitors increased 106% MoM.
Apr 16, 2026
Monthly visitors grew 41% MoM.

View all signals

Sentinel Oncology Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Sentinel Oncology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sentinel Oncology's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge

Employee Range9

Year Founded2005

Last FundingApr 1, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.